Incumbent U.S. insurers, initially keen to purchase insurtech firms, now appear to be taking more of a venture capital approach and investing in the sector instead. Download The Full Report As insurtech firms have proliferated, the number of acquisitions by property and casualty insurance buyers has dropped precipitously since 2015. Insurance companies in the space bought 12 do...
READCEOs of two U.S. biotechnology companies with less than $10 billion in market capitalization received more compensation in 2017 than their counterparts at large-caps such as AbbVie Inc. — maker of the world's best-selling medicine Humira, data pulled by S&P Global Market Intelligence showed. Douglas Ingram of Cambridge, Mass.-based Sarepta Therapeutics Inc., which develops ther...
READLatin American sovereign credit default swap prices and sovereign ratings generally stood still in most countries during the first quarter of 2018 as the region continued to see economic recovery as it prepares for a historic election cycle during the year. Brazil, Mexico, and Colombia – which will all elect new presidents in 2018 – saw CDS prices rise around 1.0% in the quarte...
READ